Outcomes in women treated with MammoSite brachytherapy or whole breast irradiation stratified by ASTRO accelerated partial breast irradiation consensus statement groups

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 1, 2012, Pages 21-29

  Zauls, A Jason ^a   Watkins, John M ^a   Wahlquist, Amy E ^b   Brackett III, N Craig ^c   Aguero, Eric G ^a   Baker, Megan K ^a   Jenrette, Joseph M ^a   Garrett Mayer, Elizabeth ^b   Harper, Jennifer L ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c Department of Surgery   (United States)

Author keywords

Brachytherapy; Breast neoplasm; Female; Local neoplasm recurrence; Radiotherapy

Indexed keywords

ACCELERATED PARTIAL BREAST IRRADIATION; BRACHYTHERAPY; BREAST NEOPLASM; COMPETING RISKS ANALYSIS; COX REGRESSION; DISEASE-FREE SURVIVAL; DUCTAL CARCINOMA; DUCTAL CARCINOMA IN SITU; FEMALE; HAZARD RATIO; KAPLAN-MEIER; LOCAL FAILURE; LONG-TERM FOLLOW-UP; LYMPH NODE; MAMMOSITE; NEOPLASM RECURRENCE; OVERALL SURVIVAL; RADIATION ONCOLOGY; RISK OF FAILURE; STATISTICAL DIFFERENCES; SURVIVAL ANALYSIS; TUMOR BED; UNIVARIATE ANALYSIS; WHOLE-BREAST IRRADIATION;

HAZARDS; IRRADIATION; ONCOLOGY; PESTICIDE EFFECTS; RADIOTHERAPY; RISK ANALYSIS; RISK PERCEPTION; TUMORS;

RADIATION;

ANTINEOPLASTIC AGENT; DOXORUBICIN;

ADULT; AGE; AGED; ARTICLE; BRACHYTHERAPY; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONSENSUS; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT FAILURE; WHOLE BREAST IRRADIATION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; AXILLA; BRACHYTHERAPY; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CHEMOTHERAPY, ADJUVANT; CONSENSUS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIATION ONCOLOGY; RISK ASSESSMENT; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT FAILURE;

EID: 83955161811     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.08.034     Document Type: Article

References (26)

1. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. B. Fisher, S. Anderson, and J. Bryant Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer N Engl J Med 347 2002 1233 1241
3. U. Veronesi, N. Cascinelli, and L. Mariani Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer N Engl J Med 347 2002 1227 1232
4. M. Clarke, R. Collins, and S. Darby Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials Lancet 366 2005 2087 2106
5. U. Veronesi, E. Marubini, and L. Mariani Radiotherapy after breast-conserving surgery in small breast carcinoma: Long-term results of a randomized trial Ann Oncol 12 2001 997 1003
6. B.V. Offersen, M. Overgaard, and N. Kroman Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: A systematic review Radiother Oncol 90 2009 1 13
7. D.W. Arthur, K. Winter, and R.R. Kuske A Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: Tumor control and survival outcomes of RTOG 95-17 Int J Radiat Oncol Biol Phys 72 2008 467 473
8. J.L. Harper, J.M. Watkins, and A.J. Zauls Six-year experience: Long-term disease control outcomes for partial breast irradiation using MammoSite balloon brachytherapy Am J Surg 199 2010 204 209
9. M. Keisch, F. Vicini, and P. Beitsch American Society of Breast Surgeons MammoSite Radiation Therapy System Registry Trial: ductal carcinoma-in-situ subset analysis - 4-year data in 194 treated lesions Am J Surg 198 2009 505 507
10. C. Polgar, J. Fodor, and T. Major Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma: 5-year results of a randomized trial Int J Radiat Oncol Biol Phys 69 2007 694 702
11. F. Vicini, P.D. Beitsch, and C.A. Quiet Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI) Cancer 112 2008 758 766
12. J.S. Vaidya, J.J. Vyas, and R.F. Chinoy Multicentricity of breast cancer: Whole-organ analysis and clinical implications Br J Cancer 74 1996 820 824
13. R. Holland, J.L. Connolly, and R. Gelman The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast J Clin Oncol 8 1990 113 118
14. P.L. Nguyen, A.G. Taghian, and M.S. Katz Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy J Clin Oncol 26 2008 2373 2378
15. Radiation Therapy Oncology Group. NSABP Protocol B-39/RTOG Protocol 0413: A Randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with stage 0, I, or II breast cancer. Available at: http://rtog.org/members/protocols/0413/0413.pdf (accessed October 26, 2009).
16. B.D. Smith, D.W. Arthur, and T.A. Buchholz Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO) Int J Radiat Oncol Biol Phys 74 2009 987 1001
17. Radiation Therapy Oncology Group. NSABP Protocol B39/RTOG Protocol 0413. A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with stage 0, I, or II breast cancer. Summary of changes: http://rtog.org/members/protocols/0413/0413soc.pdf (accessed October 26, 2009).
18. B. Fisher, J. Bryant, and J.J. Dignam Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less J Clin Oncol 20 2002 4141 4149
19. B. Fisher, J. Dignam, and N. Wolmark Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17 J Clin Oncol 16 1998 441 452
20. B. Fisher, J. Dignam, and N. Wolmark Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial Lancet 353 1999 1993 2000
21. B.M. Beadle, W.A. Woodward, and S.L. Tucker Ten-year recurrence rates in young women with breast cancer by locoregional treatment approach Int J Radiat Oncol Biol Phys 73 2009 734 744
22. K.S. Hughes, L.A. Schnaper, and D. Berry Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer N Engl J Med 351 2004 971 977
23. D.P.R. McHaffie, and J. Adkinson Outcomes following accelerated partial breast irradiation in patients with ASTRO Consensus Statement Cautionary Features [abstract] Int J Radiat Oncol Biol Phys 75 Suppl 3 2009 S76
24. L.L. Hughes, M. Wang, and D.L. Page Local excision alone without irradiation for ductal carcinoma in situ of the breast: A trial of the Eastern Cooperative Oncology Group J Clin Oncol 27 2009 5319 5324
25. J.S. Wong, C.M. Kaelin, and S.L. Troyan Prospective study of wide excision alone for ductal carcinoma in situ of the breast J Clin Oncol 24 2006 1031 1036
26. S. Hetelekidis, S.J. Schnitt, and B. Silver The significance of extracapsular extension of axillary lymph node metastases in early-stage breast cancer Int J Radiat Oncol Biol Phys 46 2000 31 34